1. Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes. Issue 6 (June 2020) Authors: Nikolic, Tatjana; Zwaginga, Jaap J; Uitbeijerse, Bas S; Woittiez, Nicky J; de Koning, Eelco J; Aanstoot, Henk-Jan; Roep, Bart O Journal: Lancet Issue: Volume 8:Issue 6(2020) Page Start: 470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗